NR1H4 and metabolic dysfunction-associated steatotic liver disease: Although serum BAs concentrations are elevated in individuals with NAFLD, the proportion of the FXR antagonistic DCA has increased, whereas the levels of the FXR agonistic CDCA have decreased (Jiao et al., 2018).